Khaled El‐Adl

3.3k total citations
90 papers, 2.8k citations indexed

About

Khaled El‐Adl is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Khaled El‐Adl has authored 90 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Organic Chemistry, 54 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Khaled El‐Adl's work include Synthesis and biological activity (39 papers), Synthesis and Biological Evaluation (26 papers) and Quinazolinone synthesis and applications (22 papers). Khaled El‐Adl is often cited by papers focused on Synthesis and biological activity (39 papers), Synthesis and Biological Evaluation (26 papers) and Quinazolinone synthesis and applications (22 papers). Khaled El‐Adl collaborates with scholars based in Egypt, Saudi Arabia and Iraq. Khaled El‐Adl's co-authors include Helmy Sakr, Abdel‐Ghany A. El‐Helby, Ibrahim H. Eissa, Hamada S. Abulkhair, Rezk R. Ayyad, Ahmed A. Al‐Karmalawy, Sanadelaslam S. A. El‐Hddad, Nour E. A. Abd El‐Sattar, Nashwa M. Saleh and Mohamed F. Zayed and has published in prestigious journals such as Molecules, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Khaled El‐Adl

88 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled El‐Adl Egypt 36 2.0k 1.3k 479 310 244 90 2.8k
Ahmed B. M. Mehany Egypt 34 1.8k 0.9× 1.2k 0.9× 349 0.7× 357 1.2× 233 1.0× 73 2.7k
Hazem Elkady Egypt 30 1.5k 0.7× 1.3k 0.9× 443 0.9× 454 1.5× 268 1.1× 94 2.3k
Bahaa G. M. Youssif Egypt 36 2.4k 1.2× 1.3k 1.0× 541 1.1× 154 0.5× 139 0.6× 127 3.2k
Hamada S. Abulkhair Egypt 34 1.5k 0.8× 902 0.7× 291 0.6× 194 0.6× 161 0.7× 68 2.2k
Mohamed Abdel‐Aziz Egypt 32 2.4k 1.2× 1.1k 0.8× 400 0.8× 175 0.6× 111 0.5× 108 3.1k
Mostafa M. Ghorab Egypt 41 3.9k 1.9× 1.7k 1.3× 384 0.8× 275 0.9× 95 0.4× 216 4.7k
Sahar M. Abou‐Seri Egypt 32 2.1k 1.0× 1.2k 0.9× 279 0.6× 193 0.6× 106 0.4× 69 2.6k
Tarfah Al‐Warhi Saudi Arabia 25 1.1k 0.5× 802 0.6× 222 0.5× 115 0.4× 129 0.5× 59 1.8k
M. Janaki Ramaiah India 29 1.5k 0.8× 1.4k 1.0× 285 0.6× 124 0.4× 60 0.2× 98 3.0k
Ahmet Özdemır Türkiye 34 2.7k 1.3× 836 0.6× 392 0.8× 160 0.5× 54 0.2× 141 3.6k

Countries citing papers authored by Khaled El‐Adl

Since Specialization
Citations

This map shows the geographic impact of Khaled El‐Adl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled El‐Adl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled El‐Adl more than expected).

Fields of papers citing papers by Khaled El‐Adl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled El‐Adl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled El‐Adl. The network helps show where Khaled El‐Adl may publish in the future.

Co-authorship network of co-authors of Khaled El‐Adl

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled El‐Adl. A scholar is included among the top collaborators of Khaled El‐Adl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled El‐Adl. Khaled El‐Adl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hozzein, Wael N., et al.. (2025). Semi-synthesis and biological activities of heterocyclic compounds containing camphor. RSC Advances. 15(17). 13199–13213. 1 indexed citations
2.
El‐Adl, Khaled, et al.. (2025). A two-decade overview of oxadiazole derivatives as promising anticancer agents. RSC Advances. 15(39). 32778–32795. 4 indexed citations
3.
Abulkhair, Hamada S. & Khaled El‐Adl. (2025). A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules. Archiv der Pharmazie. 358(3). e2500033–e2500033. 5 indexed citations
4.
El‐Sattar, Nour E. A. Abd, et al.. (2025). Dual VEGFR-2 and EGFR T790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis. Future Medicinal Chemistry. 17(3). 287–300. 5 indexed citations
5.
El‐Ghorab, Ahmed H., et al.. (2024). Biological activity and chemical characteristics studies of new oligomannose produced by Erwinia gerundensis. Carbohydrate Polymer Technologies and Applications. 8. 100569–100569. 1 indexed citations
6.
7.
Dahab, Mohammed A., et al.. (2024). Phthalazine Derivatives as VEGFR‐2 Inhibitors: Docking, ADMET, Synthesis, Design, Anticancer Evaluations, and Apoptosis Inducers. Drug Development Research. 86(1). e70037–e70037.
8.
9.
El‐Hddad, Sanadelaslam S. A., et al.. (2024). Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation. RSC Advances. 14(19). 13237–13250. 5 indexed citations
10.
El‐Adl, Khaled, et al.. (2024). Radiation synthesis and characterization of pH-Responsive sodium Alginate/Poly(acrylic acid) nanogel loaded with ferulic acid for anticancer drug delivery. Materials Chemistry and Physics. 322. 129564–129564. 12 indexed citations
11.
12.
El‐Adl, Khaled, et al.. (2023). Pyrazolo[3,4-d]pyrimidine derivatives as EGFRT790M and VEGFR-2 dual TK inhibitors: Design, synthesis, molecular docking, ADMET profile and anticancer evaluations. Journal of Molecular Structure. 1291. 136047–136047. 18 indexed citations
13.
14.
Mohamed, Abeer A., et al.. (2023). Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations. Bioorganic Chemistry. 143. 107062–107062. 13 indexed citations
15.
16.
Abdelgawad, Mohamed A., Khaled El‐Adl, Sanadelaslam S. A. El‐Hddad, et al.. (2022). Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals. 15(2). 226–226. 35 indexed citations
17.
Elwan, Alaa, Helmy Sakr, Abdel‐Ghany A. El‐Helby, et al.. (2022). Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1556–1567. 11 indexed citations
18.
Saleh, Nashwa M., et al.. (2021). Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking. Archiv der Pharmazie. 354(8). e2100085–e2100085. 42 indexed citations
19.
El‐Adl, Khaled, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, et al.. (2020). Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry. 29. 115872–115872. 85 indexed citations
20.
El‐Helby, Abdel‐Ghany A., Rezk R. Ayyad, Mohamed F. Zayed, et al.. (2019). Design, synthesis, in silico ADMET profile and GABA‐A docking of novel phthalazines as potent anticonvulsants. Archiv der Pharmazie. 352(5). e1800387–e1800387. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed B. M. Mehany Breakdown of academic impact, for papers by Hazem Elkady Breakdown of academic impact, for papers by Bahaa G. M. Youssif Breakdown of academic impact, for papers by Hamada S. Abulkhair Breakdown of academic impact, for papers by Mohamed Abdel‐Aziz Breakdown of academic impact, for papers by Mostafa M. Ghorab Breakdown of academic impact, for papers by Sahar M. Abou‐Seri Breakdown of academic impact, for papers by Tarfah Al‐Warhi Breakdown of academic impact, for papers by M. Janaki Ramaiah Breakdown of academic impact, for papers by Ahmet Özdemır
Rankless by CCL
2026